Technical Analysis for ANTX - AN2 Therapeutics, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Flat |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Fell Below 20 DMA | Bearish | 0.00% | |
Earnings Movers | Other | 0.00% | |
Wide Bands | Range Expansion | -4.31% | |
20 DMA Support | Bullish | -5.79% | |
Wide Bands | Range Expansion | -5.79% | |
Up 3 Days in a Row | Strength | -5.79% | |
Crossed Above 20 DMA | Bullish | -4.69% | |
Doji - Bearish? | Reversal | -4.69% | |
Wide Bands | Range Expansion | -4.69% | |
Wide Bands | Range Expansion | -3.94% |
Alert | Time |
---|---|
Down 3% | about 11 hours ago |
Fell Below 20 DMA | about 11 hours ago |
20 DMA Support | about 13 hours ago |
60 Minute Opening Range Breakdown | about 13 hours ago |
Down 2 % | about 13 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/08/2024
AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menlo Park, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Infectious Diseases Microbiology Tuberculosis Bacteriology Nontuberculous Mycobacteria Serious Infectious Diseases
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Infectious Diseases Microbiology Tuberculosis Bacteriology Nontuberculous Mycobacteria Serious Infectious Diseases
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 22.15 |
52 Week Low | 2.2 |
Average Volume | 331,331 |
200-Day Moving Average | 11.92 |
50-Day Moving Average | 2.85 |
20-Day Moving Average | 2.48 |
10-Day Moving Average | 2.45 |
Average True Range | 0.18 |
RSI (14) | 34.64 |
ADX | 37.36 |
+DI | 17.58 |
-DI | 30.95 |
Chandelier Exit (Long, 3 ATRs) | 2.63 |
Chandelier Exit (Short, 3 ATRs) | 2.75 |
Upper Bollinger Bands | 2.80 |
Lower Bollinger Band | 2.16 |
Percent B (%b) | 0.44 |
BandWidth | 25.51 |
MACD Line | -0.27 |
MACD Signal Line | -0.38 |
MACD Histogram | 0.1059 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 2.67 | ||||
Resistance 3 (R3) | 2.69 | 2.64 | 2.63 | ||
Resistance 2 (R2) | 2.64 | 2.58 | 2.63 | 2.61 | |
Resistance 1 (R1) | 2.54 | 2.55 | 2.52 | 2.52 | 2.60 |
Pivot Point | 2.49 | 2.49 | 2.48 | 2.48 | 2.49 |
Support 1 (S1) | 2.39 | 2.43 | 2.37 | 2.37 | 2.28 |
Support 2 (S2) | 2.34 | 2.40 | 2.33 | 2.27 | |
Support 3 (S3) | 2.24 | 2.34 | 2.25 | ||
Support 4 (S4) | 2.22 |